These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 30982973

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells.
    Gu X, Zerbini LF, Otu HH, Bhasin M, Yang Q, Joseph MG, Grall F, Onatunde T, Correa RG, Libermann TA.
    Cancer Res; 2007 May 01; 67(9):4219-26. PubMed ID: 17483333
    [Abstract] [Full Text] [Related]

  • 4. Signatures of prostate-derived Ets factor (PDEF) in cancer.
    Mahajan N.
    Tumour Biol; 2016 Nov 01; 37(11):14335-14340. PubMed ID: 27612480
    [Abstract] [Full Text] [Related]

  • 5. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
    Tsui KH, Chung LC, Feng TH, Chang PL, Juang HH.
    Int J Cancer; 2012 Jun 15; 130(12):2812-23. PubMed ID: 21780100
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF.
    Johnson TR, Koul S, Kumar B, Khandrika L, Venezia S, Maroni PD, Meacham RB, Koul HK.
    Mol Cancer; 2010 Jun 15; 9():148. PubMed ID: 20550708
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. PDEF in prostate cancer.
    Sood AK, Kim H, Geradts J.
    Prostate; 2012 May 01; 72(6):592-6. PubMed ID: 21796651
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Loss of P53 facilitates invasion and metastasis of prostate cancer cells.
    Wang Y, Zhang YX, Kong CZ, Zhang Z, Zhu YY.
    Mol Cell Biochem; 2013 Dec 01; 384(1-2):121-7. PubMed ID: 23982184
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma.
    Sun F, Wang J, Sun Q, Li F, Gao H, Xu L, Zhang J, Sun X, Tian Y, Zhao Q, Shen H, Zhang K, Liu J.
    J Exp Clin Cancer Res; 2019 Nov 04; 38(1):449. PubMed ID: 31684995
    [Abstract] [Full Text] [Related]

  • 18. Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma.
    Yang SH, Lin HY, Changou CA, Chen CH, Liu YR, Wang J, Jiang X, Luh F, Yen Y.
    Oncotarget; 2016 Jan 05; 7(1):362-73. PubMed ID: 26517522
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.